Predictive oncology inc. ceo provides updates on subsidiaries, highlights recent milestones and near-term goals

New york, oct. 27, 2020 (globe newswire) -- via networknewsaudio — predictive oncology inc. (nasda q : poai) today announces that its chief executive officer, carl schwartz, has been featured in an exclusive audio interview with networknewswire (“nnw”), a financial news and content distribution company and one of 50+ brands in the investorbrandnetwork (“ibn”). during the interview, schwartz provided an update on the company's recent milestones and near-term goals following the october release of his letter t o shareholders. in particular, schwartz put a focus on the company's subsidiaries: skyline medical, tumorgenesis, soluble biotech and helomics.
POAI Ratings Summary
POAI Quant Ranking